Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla
Clinical trials sponsored by Fundación Pública Andaluza Para La Gestión De La Investigación En Sevilla, explained in plain language.
-
Can a Salt-Marsh plant extract help control cholesterol?
Disease control Not yet recruitingThis study tests whether a dietary supplement made from halophyte plant extracts (like salicornia) and B vitamins can improve cholesterol levels in people recently diagnosed with dyslipidemia who do not yet need medication. About 250 participants will take the supplement or follo…
Phase: NA • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Could a heart drug beat a deadly blood infection? new trial aims to find out
Disease control Not yet recruitingThis study tests whether adding clopidogrel, a drug usually used to prevent blood clots, to standard antibiotics improves outcomes for adults with a serious Staphylococcus aureus bloodstream infection. About 230 hospitalized patients will be randomly assigned to receive clopidogr…
Phase: PHASE2 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
AI-Powered therapy for teens shows promise in new trial
Symptom relief Not yet recruitingThis study tests AGENCIA, a brief psychological program supported by digital technology and artificial intelligence, to help teens aged 12-18 with emotional and behavioral difficulties like irritability, impulsivity, and conflicts. Participants are randomly assigned to an online …
Phase: NA • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
New hope for Hard-to-Treat depression in seniors: esketamine spray vs aripiprazole
Symptom relief Not yet recruitingThis study compares two add-on treatments—esketamine nasal spray and aripiprazole pills—for older adults (60-74) whose depression hasn't improved with standard antidepressants. Around 220 participants will receive either esketamine once or twice weekly or daily aripiprazole, alon…
Phase: PHASE3 • Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Symptom relief
Last updated Jun 26, 2026 13:33 UTC
-
New study aims to predict deadly infections in blood cancer patients
Knowledge-focused Not yet recruitingThis study looks at blood cancer patients who carry drug-resistant bacteria in their gut. Researchers want to find out who is most likely to get a serious infection from these bacteria. They will collect rectal swabs and track patients for 90 days to build a prediction tool. The …
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC